US FDA grants priority review status to Sanofi’s BLA for avalglucosidase alfa to treat Pompe disease
The US Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application (BLA) for avalglucosidase alfa for long-term... Read More
What are therapeutic biological products?
A biological product is a substance derived from a living organism and used for the prevention or treatment of disease. Biologicals are... Read More